MedPath

Medical Treatment Alone Versus Varicocelectomy Versus Varicocelectomy and Medical Treatment

Not Applicable
Recruiting
Conditions
Teratozoospermia
Interventions
Registration Number
NCT07016867
Lead Sponsor
South Valley University
Brief Summary

A varicocele is defined as an abnormal venous dilatation and/or tortuosity of the pampiniform plexus in the scrotum. Although varicoceles are almost always and more common on the left side, up to 50% of the men with varicocele, have bilateral varicoceles.

Varicocele has a negative impact on spermatogenesis, testicular volume, Standard semen parameters, and fertilization, implantation, and embryo outcomes.

Detailed Description

Varicocelectomy remains the first-line treatment option in infertile men with palpable varicocele and abnormal semen parameters, with the microsurgical subinguinal approach conveying the greatest success rate and fewest complications. The empirical use of antioxidant supplement may confer some benefits in men to reduce oxidative damage.

Medical management, including antioxidants, could offer a potential solution with lower risks given the increasing evidence suggesting the role of oxidative stress in varicocele-induced infertility.

Physical examination of the scrotum remains the most commonly used technique to diagnose varicoceles. Palpation of the scrotum is best performed in a relaxed patient in standing position, in a warm room and carried out by a well-trained physician.

Surgical treatment of varicocele has a significant effect on semen parameters, so it is considered the 'gold standard' treatment for subfertile males with palpable varicoceles associated with abnormal semen analysis.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
126
Inclusion Criteria
  • Sub-fertile men with clinically palpable varicoceles ( unilateral or bilateral ).
  • Men with teratozoospermia.
Exclusion Criteria
  • Recurrent varicoceles.
  • Significant medical diseases as: Hepatic insufficiency.
  • Hypersensitivity to the drugs.
  • Female factor of infertility.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group of l-carnitine and antioxidantl-carnitineAbout 42 male patients suffering from teratozoospermia will take medical treatment (l-carnitine and antioxidant) once daily for 3 months
Group of varicocelectomyl-carnitineAbout 42 male patients suffering from teratozoospermia will undergo subinguinal varicocelectomy.
Group of Mixed Treatment(varicocelectomy then l-carnitine and antioxidant)l-carnitineAbout 42 male patients suffering from teratozoospermia will undergo subinguinal varicocelectomy then adjuvant treatment (l-carnitine and antioxidant) for 3 months.
Primary Outcome Measures
NameTimeMethod
Number of participants with Treatment of Teratozoospermia3 months

Treatment of the male patients that suffering from abnormally shaped sperms (Teratozoospermia) by medical treatment and or subinguinal varicocelcetomy

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

South Valley University Hospital

🇪🇬

Qinā, South Valley, Egypt

South Valley University Hospital
🇪🇬Qinā, South Valley, Egypt
Omar Mohamed El-Saghier, Assist.Prof
Contact
+201095421734
Omarelsoqier1983@yahoo.com
Atef Fathi Ali, Assist.Prof
Contact
+201111380109
ateffathi2010@yahoo.com
© Copyright 2025. All Rights Reserved by MedPath